Company / Interest Expense
GeneDx Holdings Corp. Interest Expense History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$3.2M
FY2022
5-year range
$2.8M / $3.2M
FY2019-FY2022
Trend
+13.1%
vs FY2021
Sector context
#38 of 40
Health Care
What the data says
Among 40 Health Care companies, GeneDx Holdings Corp. is in the top 5% for interest expense. Interest Expense has increased for 3 consecutive years, from $783,000 in FY2019 to $3M in FY2022.
Based on SEC 10-K filings.
$3M in FY2022 with a 3-year CAGR of +60.0%.
Increased from $2M to $3M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +60.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 40This company $3.2M Sector average $332.7M
▼
-99.0% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s interest expense has grown for 3 consecutive years.
- 3-year CAGR of +60.0%, indicating consistent growth.
- In FY2022, interest expense increased 13.1% year-over-year.
- Ranks #38 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $3.2M | +13.1% |
| FY2021 | $2.8M | +14.6% |
| FY2020 | $2.5M | +216.0% |
| FY2019 | $783.0K | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026